Clinically, elevated circulating TNF-α predicts poor prognosis in colorectal, breast, and lung cancers, while pilot studies in HF cohorts link higher TNF-α concentrations to cachexia, sarcopaenia, and adverse ventricular remodeling (15–17). Here, TNF is linked to lung carcinoma.